Patient Group Directions (PGDs) provide a legal framework that allows some registered health professionals to supply and/or administer a specified medicine(s) to a pre-defined group of patients, without them having to see a doctor (or dentist) or non-medical prescriber.

PGDs are NOT intended as a substitute for individual prescribing where there is an opportunity in the care pathway for a medicine or medicines to be prescribed i.e. where an episode of care is planned.

PGDs must only include medicines with a UK marketing authorisation, in line with national legislation. Off-label use of a licensed medicine in a PGD is considered only when clearly justified by best clinical practice.

Only formulary drugs can be approved for inclusion on a PGD.

A PGD must only be written after careful consideration of all the available methods of administration and supply of medicines, including prescribing by medical or non-medical prescribers.


Policy Details

Download: N/A
Compiled by: Olatokunbo Ogunbanjo, Chief Pharmacist
Ratified by: Drug and Therapeutics Committee
Date Ratified: October 2021
Date Issued: October 2021
Review Date: October 2024
Target Audience: Doctors, Nurses, Pharmacy, Allied Health Care Professionals
Contact name: Olatokunbo Ogunbanjo, Chief Pharmacist


See also:


Protecting Your Online Privacy
Protecting Your Online Privacy

This Ashford and St Peter's website uses cookies to track visitor numbers. Find out more in our Cookies Policy and Privacy Policy. You can also read our Accessibility Statement and Privacy Notice for your information.